Saturday, January 24, 2026 8:33:34 PM
While I believe that DCVax-L used earlier is best, but I don't know that in some cases, even when used later it's so effective that patients haven't become long term survivors. This may be especially true if it's combined with Keytruda and/or Poly-ICLC.
If this is true for GBM patients, it may be true for other patients who initiate treatment with the SOC for that cancer, but when determined that it's not achieving what's hoped for, DCVax-L perhaps with other therapeutics could be used and be of great benefit perhaps ultimately curing the patient.
Certainly, it might be better if included for every patient from the beginning, that's doubtful especially for cancers where current treatment is largely successful. For the deadliest of cancers, it ought to become a part of the SOC once it's determined to be of benefit.
I view pancreatic as one of the deadliest and while there is very little data, from what I gather patients who've tried it had benefits. To me, that's enough to make it part of the SOC. I would hope that for patients whose tumors were not suitable to the Whipple enough of the lysate could somehow be obtained to make the vaccine. I don't know if something can remotely suck sufficient tumor through it to do the job, something like a needle biopsy but larger and designed to break down the tumor and suck it out in sufficient quantity to make the vaccine. I don't know if such a device exists, but if not, I've got to believe it's possible. If not, DCVax-Direct may be the answer, but not until it's proven to be.
If a device can get adequate lysate to make the vaccine from otherwise inoperable tumors, the question may be, what's more effective, DCVax-L requiring extraction of some tumor lysate, or DCVax-Direct which is simply injected into the tumor.
A friend has stage 4 breast cancer, I know it's inoperable, but again, I would believe that there is a way to get sufficient tumor to make the vaccine. I would hope it could be done without surgery per se, but with some device like I described. Some might consider that minor surgery, I don't know.
Gary
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
